Session 1 - Lecture 0 Flashcards
1
Q
3 - Context – Why CPT?
A
- Number of drugs available to prescribe is increasing – can be good!
- 1.2 billion prescription items dispensed for last whole year of data - 2017 (population of ~ 55M)
- Almost all broad categories are increasing - more choice and number of prescriptions
- HT, HF and HL make up the greatest proportion of prescribed drugs
- Prescribing errors! Writing prescriptions, other clinicians prescribing, polypharmacy
{1. good bc means we’re better at targeting specific conditions but also means needs more working knowledge of drugs available!
- ~30-40 prescriptions a day per doctor! including repeat or new - you need to make important decisions on whether appropriate and how it should be prescribed
- Most prescribed drugs in CV disease category. hypertension, heart failure, hyperlipidaemia - Statins (greatest proportion of drugs) are a group of medicines that can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood.
- MDT aspect to writing scripts: lots of people involved. Polypharmacy - average UK senior citizen takes at least 7 or 8 meds at 1 time - so when you add/take away a drug need to think about other interactions}
2
Q
4 - Previous feedback and some changes
A
- Evidence - used to base decisions on px, explain why particular drugs are or are not used. Need to know this for making decisions when qualified.
- Digoxin - not first-line therapy anymore but still relevant - about 3,000,000 scripts a year (3000 scripts/month - so will need to consider it 3-4x/month per doctor)
3
Q
6 - Sessions
A
- Sessions will be grouped as themed, e.g. HT, HF and diuretics
- Polypharmacy - theme that will run throughout unit (consider disease state, multiple therapeutics being px).
- Anaesthetics - stand-alone intro for Phase 2 surgery placements
- Chemotherapy - stand-alone session but whatever field you go into you will encounter a chemo pt, so these drugs will be vital to know
- Clinical trials important in CPT, and EBM - consider clin trials, EBM, how to interpret guidelines - critique and make considerations about whether to use something or not.
4
Q
7 - Longitudinal themes
A
Longitudinal themes
- Review of relevant background and concepts
- Pharmacological Mechanisms of Action
- Pharmacokinetics and Pharmacodynamics
- Clinical Indications for Therapeutics
- Important and Common Adverse Drug Reactions (ADRs)
- Important Drug-Drug Interactions (DDIs)
- Drug Monitoring during Therapy
- Evidence Supporting Therapeutic Use - Clinical Trials
{Each lecture is own subject but within each lecture need to consider below
- pathophysiology
- links to PK
- PK = how a body deals with a drug; PD = how the drug is acting on the body
- where it’s appropriate to prescribe a drug, under what conditions/presentation
- some more obvious than others.
- polypharmacy - need good pt hx to ascertain
- monitor for cytotoxicity, narrow therapeutic window; but also to actually monitor effect of the drugs – hope the drug is going to do what you hope it’s going to do e.g. reduce BP.
- consider evidence base}
5
Q
7
A
7
6
Q
8
A
8
7
Q
9
A
9
8
Q
10
A
10
9
Q
11
A
11
10
Q
12
A
12
11
Q
13
A
13
12
Q
14
A
14
13
Q
15
A
15